Twitter Crumbles After Shares Unlock and Pfizer/Astrazeneca Deal Sparks Fears
Twitter, Inc. (NYSE: TWTR) shares sank after a huge amount of the company's stock was unlocked this week. The unlock of shares allowed shareholders in the firm who have long held the company's stock to sell their equity. As a result shares of Twitter sank more than 11%. In comparison Facebook soared more than 10% the day the company unlocked 800 million Facebook shares.
Twitter, Inc. is a global platform for public self-expression and conversation in real time. It provides various products for users, including Twitter that allows users to express themselves and create, distribute, and discover content; Vine, a mobile application available on the iOS, Android, and Windows operating systems that enables users to create and distribute short looping videos; and #Music, a mobile application that helps users discover new music and artists based on Tweets.
Get more information on Twitter, Inc. and free access to the in depth equity report at: www.TrendingWallStreet.com/stockquote/TWTR
TrendingWallStreet.com wants to help everyday people gain awareness about some of the hottest penny stocks trading in the stock market today. TrendingWallStreet.com releases momentum alerts on companies that you may have never heard about or thought about looking at. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get full access to our free stock reports.
Pfizer Inc. (NYSE: PFE) has proposed a $106 billion takeover of AstraZeneca, Britain's second-largest drugs company, in a deal that the company says would bolster innovative science and speed the development of new treatments. The deal, which would be the largest foreign takeover of any British company has sparked fears over skilled job losses. Combining the two companies would create the world's largest pharmaceuticals business and would save Pfizer billions of dollars in taxes by moving its domicile to Britain.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The companys Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimers disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation.
Get more information on Pfizer Inc. and free access to the in depth equity report at: www.TrendingWallStreet.com/stockquote/PFE
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.